Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-03 @ 9:17 AM
Study NCT ID:
NCT03370159
Status:
WITHDRAWN
Last Update Posted:
2018-08-01
First Post:
2017-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer
Sponsor:
Wake Forest University Health Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-04
First Submit QC Date:
None
Study First Post Date:
2017-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-30
Last Update Post Date:
2018-08-01
Last Update Post Date Type:
ACTUAL